{"gene":"NFKBIA","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1998,"finding":"Crystal structure of the IκBα ankyrin repeat domain bound to a truncated NF-κB (p50/p65) heterodimer at 2.7 Å resolution reveals that six IκBα ankyrin repeats contact the C-terminal Rel homology regions of NF-κB in discontinuous patches; the first two repeats cover an alpha-helically ordered segment containing the p65 NLS, and the sixth repeat position indicates that full-length IκBα occludes the NF-κB DNA-binding cleft.","method":"X-ray crystallography","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution crystal structure with functional interpretation; landmark single study with multiple orthogonal structural analyses","pmids":["9865693"],"is_preprint":false},{"year":1998,"finding":"The F-box/WD-domain protein E3RSIκBα (β-TrCP) was identified as the receptor component of the pIκBα-ubiquitin ligase (pIκBα-E3) that specifically recognizes phosphorylated IκBα and promotes its in vitro ubiquitination in the presence of E1 and UBC5C; an F-box-deletion dominant-negative mutant blocked pIκBα degradation and NF-κB activation in vivo.","method":"Immunoaffinity purification from HeLa cells, nanoelectrospray mass spectrometry, in vitro ubiquitination assay, dominant-negative in vivo experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reconstituted in vitro ubiquitination, MS identification, confirmed with dominant-negative in vivo; single rigorous study with multiple orthogonal methods","pmids":["9859996"],"is_preprint":false},{"year":1996,"finding":"Signal-induced NF-κB activation requires phosphorylation-dependent ubiquitination of IκBα: TNFα stimulation causes rapid accumulation of multi-ubiquitinated IκBα that dissociates from NF-κB when proteasomal degradation is blocked; an S32A/S36A IκBα mutant that cannot be phosphorylated also fails to undergo inducible ubiquitination, placing phosphorylation upstream of ubiquitination and proteasomal degradation.","method":"Proteasome inhibitor treatment, recombinant ubiquitin carboxyl-terminal hydrolase de-ubiquitination assay, anti-ubiquitin immunoprecipitation, epitope-tagged ubiquitin Western blot, site-directed mutagenesis","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal biochemical methods plus mutagenesis in a single rigorous study; foundational mechanistic result","pmids":["8631829"],"is_preprint":false},{"year":2008,"finding":"Two distinct degradation pathways control IκBα levels: free IκBα is degraded rapidly in a ubiquitin-independent, PEST-domain-dependent manner by the proteasome, whereas NF-κB-bound IκBα is protected from this pathway and requires IKK phosphorylation and ubiquitination for slower basal degradation. NF-κB binding masks the PEST domain from proteasomal recognition.","method":"Biochemical fractionation, proteasome inhibitor assays, ubiquitination assays, PEST-domain deletion/mutation analysis, quantitative protein half-life measurements","journal":"The EMBO Journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal biochemical methods distinguishing two degradation pathways; rigorous mechanistic dissection","pmids":["18401342"],"is_preprint":false},{"year":1999,"finding":"IκBα (when not bound to NF-κB) is constitutively and actively imported into the nucleus via an energy-dependent, importin α/β- and Ran-dependent mechanism that requires the ankyrin repeats of IκBα and additional factor(s) recognizing those repeats ('piggy-back' mechanism); binding to NF-κB retains IκBα in the cytoplasm.","method":"Nuclear import assays using digitonin-permeabilized cells, energy-depletion experiments, ankyrin-repeat competition/depletion from cell extracts, subcellular fractionation","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct nuclear transport assays with multiple biochemical manipulations in a single focused study","pmids":["10037782"],"is_preprint":false},{"year":2000,"finding":"The cytoplasmic protein G3BP2 (RasGAP SH3-binding protein 2) interacts with both free IκBα and IκBα/NF-κB complexes via the N-terminal domain of IκBα, and its overexpression promotes cytoplasmic retention of IκBα, adding cytoplasmic anchoring to nuclear import/export as a mechanism controlling IκBα localization.","method":"Co-immunoprecipitation, pulldown, overexpression localization experiments, domain-mapping","journal":"The Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, reciprocal co-IP plus overexpression functional assay; two complementary methods","pmids":["10969074"],"is_preprint":false},{"year":2001,"finding":"CK2 phosphorylation of serine/threonine residues in the PEST domain of IκBα (S283, T291, T299) promotes calpain-mediated degradation of IκBα, as demonstrated by in vitro CK2 phosphorylation/calpain degradation assays; a 3CIκBα mutant (S283A/T291A/T299A) resists calpain-mediated degradation, identifying a non-canonical degradation route active in IgM+ B cells.","method":"In vitro phosphorylation/degradation assay, site-directed mutagenesis (S283A/T291A/T299A), calpain inhibitor experiments, CK2 inhibitor (apigenin) treatment","journal":"Journal of Immunology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstituted phosphorylation-degradation assay with mutagenesis; single lab but mechanistically rigorous","pmids":["11673497"],"is_preprint":false},{"year":2003,"finding":"An IKK-independent IκBα degradation pathway exists: in IKK1/2−/− MEFs, doxorubicin induces IκBα degradation that does not require S32/S36 phosphorylation or the PEST domain, is partially blocked by PI3-kinase inhibitor LY294002, and is proteasome-dependent; the released NF-κB can activate chromatin-based reporter genes.","method":"IKK1/2 double-knockout MEFs, phospho-mutant IκBα, PI3-kinase inhibitor, proteasome inhibitor, NF-κB chromatin reporter assay","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — genetic knockout combined with pharmacological dissection and reporter assays; rigorous mechanistic characterization","pmids":["14585967"],"is_preprint":false},{"year":2006,"finding":"14-3-3 proteins physically interact with IκBα (residues 60–65) and with p65, and are required for efficient CRM1-dependent nuclear export of p65-IκBα complexes; mutations in the 14-3-3 binding domains cause nuclear accumulation of both proteins, and dominant-negative 14-3-3 leads to constitutive chromatin association of p65 with loss of TNFα responsiveness.","method":"Co-immunoprecipitation, domain-mapping mutagenesis, dominant-negative overexpression, ChIP, subcellular fractionation, fluorescence microscopy","journal":"Journal of Cell Science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP, mutagenesis, dominant-negative functional assay, and ChIP in a single study; multiple orthogonal methods","pmids":["16931600"],"is_preprint":false},{"year":2007,"finding":"Ionizing radiation activates NF-κB by a mechanism in which constitutive NO synthase activation leads to nitration of IκBα tyrosine 181, causing dissociation of intact IκBα from NF-κB without requiring IKK-dependent phosphorylation or proteolytic degradation of IκBα; crystallographic analysis shows Y181 is involved in noncovalent contacts with NF-κB p50.","method":"Cell-based NF-κB assays, NO synthase inhibitors, mutational analysis of Y181, hydropathic analysis of crystal structure contacts","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Weak — functional cell assays with pharmacological inhibitors and structural rationale; single lab, limited direct mutagenesis reconstitution","pmids":["17910475"],"is_preprint":false},{"year":2008,"finding":"Stabilizing mutations in IκBα ankyrin repeats 5–6 cause them to pre-fold cooperatively; pre-folded IκBα is degraded more slowly by the ubiquitin-independent proteasome pathway, binds NF-κB more weakly (shown by SPR, ITC, and immunoprecipitation), and results in incomplete NF-κB inhibition at rest and reduced nuclear NF-κB upon stimulation, demonstrating that coupled folding-and-binding of IκBα is critical for NF-κB control.","method":"Stabilizing mutagenesis of AR5–6, surface plasmon resonance, isothermal titration calorimetry, co-immunoprecipitation, pulse-chase protein half-life assay in cells","journal":"Journal of Molecular Biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted binding measurements plus mutagenesis plus cell-based half-life assays; multiple orthogonal methods in single study","pmids":["18511071"],"is_preprint":false},{"year":2012,"finding":"TNFα stimulation induces formation of heterologous SUMO-2/3-ubiquitin chains on IκBα; deficient SUMOylation (Ubc9 silencing) delays TNFα-mediated IκBα proteolysis and NF-κB-dependent transcription; hybrid SUMO-2/3-ubiquitin chains promote more efficient degradation of IκBα by the 26S proteasome in vitro compared with either modification alone.","method":"In vitro proteasome degradation assay with hybrid chains, TUBE-based ubiquitin-trap capture, Ubc9 siRNA knockdown, TNFα stimulation assays","journal":"PloS One","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro reconstituted proteasome assay plus cell-based RNAi; single lab with two orthogonal methods","pmids":["23284737"],"is_preprint":false},{"year":2013,"finding":"The p97-UFD1L-NPL4 protein complex mediates the post-ubiquitinational step of IκBα proteolysis after TNFα or IL-1β stimulation: p97 associates with the SCFβ-TRCP ubiquitin ligase, and UFD1L's polyubiquitin-binding domain binds polyubiquitinated IκBα; ATPase activity of p97 is essential for efficient IκBα degradation and NF-κB activation.","method":"Co-immunoprecipitation, ATPase-dead p97 mutant, siRNA knockdown, TNFα/IL-1β stimulation assays","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP with ATPase mutant and knockdown validation; single lab, two orthogonal methods","pmids":["24248593"],"is_preprint":false},{"year":2001,"finding":"IκBα can sequester ribosomal protein S3 (RPS3) in the cytoplasm: in resting HEK293 cells, RPS3 co-precipitates with IκBα; in vitro reconstitution shows strong direct IκBα–RPS3 binding but weak RPS3–p65 binding; IκBα facilitates assembly of p65 and RPS3 into a trimeric complex, suggesting equimolar co-release of RPS3 and p65 upon stimulation.","method":"Co-immunoprecipitation, in vitro binding (pulldown), reconstitution of trimeric complex","journal":"FEBS Letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP combined with in vitro reconstitution; single lab","pmids":["24457201"],"is_preprint":false},{"year":2017,"finding":"IκBα binding to NF-κB induces long-range allosteric conformational changes: amide H/D exchange shows that IκBα binding to the dimerization domains globally stabilizes the DNA-binding domains, whereas DNA binding increases exchange in the NLS region, consistent with a 'molecular stripping' mechanism whereby IκBα electrostatically repels DNA and twists the NF-κB heterodimer.","method":"Hydrogen/deuterium exchange mass spectrometry (HDX-MS), coarse-grained molecular dynamics simulations","journal":"Journal of Molecular Biology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — structural biophysics with HDX-MS; single lab, no mutagenesis confirmation of specific contacts","pmids":["28249778"],"is_preprint":false},{"year":2021,"finding":"Transcriptional silencing of NFKBIA (encoding IκBα) by the histone demethylase KDM5B mediates constitutive NF-κB activation in senescent cells: during the second phase of DNA-damage-induced NF-κB activation, altered GSK3β-dependent phosphorylation of p65/RelA leads to NFKBIA transcriptional repression and IKK-independent, proteasome-independent NF-κB activity.","method":"RNA-seq, ChIP-seq, GSK3β inhibitor treatment, IKK inhibitor treatment, proteasome inhibitor treatment, siRNA knockdown","journal":"The EMBO Journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide ChIP-seq and RNA-seq plus pharmacological dissection; single lab, multiple orthogonal approaches","pmids":["33459422"],"is_preprint":false},{"year":2023,"finding":"The histone demethylase KDM5B is recruited to the Nfkbia promoter in activated macrophages and erases H3K4me3 marks, reducing chromatin accessibility and suppressing IκBα expression to permit full NF-κB activation; KDM5B deficiency or inhibition protects mice from inflammatory disease models.","method":"Genome-wide ChIP-seq (KDM5B binding peaks), ATAC-seq (chromatin accessibility), KDM5B KO mice, inhibitor treatment, collagen-induced arthritis and endotoxin shock models","journal":"Cell Death and Differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq, ATAC-seq, genetic KO, and in vivo disease models; multiple orthogonal methods with in vivo validation","pmids":["36914768"],"is_preprint":false},{"year":2022,"finding":"Hexokinase 2 (HK2) acts as a protein kinase that phosphorylates IκBα at T291 upon high-glucose stimulation; this phosphorylation increases IκBα interaction with μ-calpain, leading to μ-calpain-mediated IκBα degradation, NF-κB activation, and PD-L1 upregulation; expression of IκBα T291A blocked these effects.","method":"Co-immunoprecipitation, in vitro kinase assay, T291A phospho-mutant, calpain inhibitors, shRNA knockdown, orthotopic tumor models","journal":"Cell Metabolism","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay plus phospho-mutant plus co-IP plus in vivo xenograft; multiple orthogonal methods in single study","pmids":["36007522"],"is_preprint":false},{"year":2020,"finding":"TRIM22 E3 ubiquitin ligase directly binds IκBα (by co-immunoprecipitation), promotes K48-linked ubiquitination of IκBα accelerating its degradation, and also forms a complex with IKKγ to promote K63-linked ubiquitination leading to IKKα/β phosphorylation; RING-domain or active-site TRIM22 mutants fail to promote GBM cell proliferation.","method":"Co-immunoprecipitation, luciferase reporter assay, RING-domain deletion and C15/18A active-site mutagenesis, CRISPR/Cas9 knockout, orthotopic xenograft","journal":"Cell Death and Differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with E3 ligase mutants and in vivo xenograft; single lab, multiple complementary methods","pmids":["32814880"],"is_preprint":false},{"year":2020,"finding":"HDAC4 acts as a SUMO E3 ligase (via its Cys292) that directly sumoylates IκBα; IκBα sumoylation at Lys21 competes with K48-linked polyubiquitination at the same residue, thereby preventing IκBα degradation and inhibiting NF-κB activation; cytoplasmic localization of HDAC4 is required for this activity.","method":"SUMO E3 ligase assay, co-immunoprecipitation, HDAC4 Cys292 mutagenesis, Lys21 IκBα mutation, subcellular fractionation","journal":"Journal of Molecular Cell Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct sumoylation assay with key-residue mutagenesis; single lab, two orthogonal methods","pmids":["32770227"],"is_preprint":false},{"year":2023,"finding":"Gluconeogenic enzyme FBP1 directly dephosphorylates IκBα at S32/S36 upon TNFα stimulation: identified by phosphoproteomic analysis, confirmed by molecular docking and MD simulations showing catalytic mechanism analogous to F-1,6-BP dephosphorylation; FBP1-IκBα interaction established by co-immunoprecipitation; FBP1-dependent IκBα dephosphorylation inhibits NF-κB and suppresses colorectal tumorigenesis.","method":"High-throughput screening with molecular docking/MD simulations, phosphoproteomic analysis, co-immunoprecipitation, FBP1 overexpression/knockdown, colorectal tumor xenograft models","journal":"Cell Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphoproteomics plus co-IP plus in vivo models; computational predictions supported by experimental biochemistry; single lab","pmids":["36646759"],"is_preprint":false},{"year":2015,"finding":"GRK6 directly phosphorylates IκBα at Ser32/Ser36 in vitro and in cells; TNFα induces a conformational change in GRK6 (detected by BRET probe), and GRK6 kinase activity promotes NF-κB signaling and inflammatory gene transcription after TNFα stimulation; GRK6 knockout in macrophages attenuates this response.","method":"In vitro kinase assay, GRK6 knockout macrophages, BRET conformational sensor, TNFα stimulation assays","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay plus genetic knockout plus BRET sensor; single lab, multiple methods","pmids":["25881508"],"is_preprint":false},{"year":2013,"finding":"BCL10, MALT1, and IKK inducibly associate with IκBα in a complex physically distinct from the early CK1α-CBM signalosome during TCR signaling; siRNA knockdown of CARMA1, CK1α, or BCL10 prevents assembly of this IκBα-containing complex and reduces NF-κB activation; IκBα knockdown alters BCL10-MALT1 ubiquitylation, suggesting IκBα participates in MALT1 recycling.","method":"Co-immunoprecipitation, siRNA knockdown (CARMA1, CK1α, BCL10, IκBα), T-cell receptor stimulation assays","journal":"Journal of Cell Science","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — reciprocal co-IP with siRNA validation; single lab, two orthogonal approaches","pmids":["20551178"],"is_preprint":false},{"year":2018,"finding":"Bmi1 polycomb protein associates with the SCF ubiquitin complex via its N-terminus and, following IKKα/β-dependent phosphorylation, promotes IκBα ubiquitination in the cytoplasm; Bmi1 deficiency inhibits NF-κB-mediated gene expression and an NF-κB-dependent arthritis model in vivo.","method":"Co-immunoprecipitation, Bmi1 N-terminal deletion mutants, IKK inhibitor, Bmi1 knockout, collagen-induced arthritis model","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with domain mapping plus in vivo disease model; single lab","pmids":["30209188"],"is_preprint":false},{"year":2018,"finding":"USP14 deubiquitinating enzyme interacts with IκBα and promotes its deubiquitination and degradation (paradoxically exacerbating NF-κB activation), thereby creating a feed-forward loop that aggravates IL-1β-induced chondrocyte dedifferentiation; USP14 upregulation itself depends on NF-κB pathway activity.","method":"Co-immunoprecipitation, USP14 overexpression/knockdown, IKK-β inhibitor (ACHP), Western blot, chondrocyte differentiation assays","journal":"Life Sciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single co-IP with functional assays; the described USP14 mechanism (promoting degradation via deubiquitination) is counterintuitive and lacks in vitro reconstitution","pmids":["30550885"],"is_preprint":false},{"year":2019,"finding":"Hypoxia (1% O2) inhibits RANKL-dependent phosphorylation of IκBα in osteoclast precursors, thereby suppressing NFATc1 expression and osteoclast differentiation and bone resorption.","method":"RAW264.7 cells and bone marrow monocytes in hypoxic chamber, RANKL stimulation, Western blot for p-IκBα and p-JNK, TRAP staining, bone resorption assay","journal":"Inflammation Research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, descriptive Western blot correlation between hypoxia and IκBα phosphorylation; no mechanistic reconstitution of hypoxia-IκBα link","pmids":["30604211"],"is_preprint":false},{"year":2019,"finding":"Hypoxia induces rapid, transient accumulation of both RelA and IκBα within mitochondria in a ROS- and STAT3-dependent manner; STAT3 inhibition blocks mitochondrial RelA and IκBα localization; p50 is instead found in the ER and RelA alone is present in the mitoplast.","method":"Subcellular fractionation (mitochondria isolation), mitoplast fractionation, hypoxia treatment, ROS scavenger, STAT3 inhibitor, Western blot","journal":"Bioscience Reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct fractionation with organelle sub-fractionation plus pharmacological inhibitors; single lab but multiple orthogonal approaches","pmids":["31484794"],"is_preprint":false},{"year":2021,"finding":"Phosphorylated IκBα (pS-IκBα) binds to nucleosomes via histones H2A and H4; serine 32/36 phosphorylation of IκBα favors its binding to nucleosomes; this association depends on acetylation of specific H4 lysine residues; proteolytic cleavage of the H4 N-terminal tail by trypsin/chymotrypsin reduces pIκBα chromatin binding; dynamic chromatin binding of IκBα is required for intestinal cell differentiation.","method":"Chromatin immunoprecipitation, co-immunoprecipitation with nucleosome components, phospho-mutant IκBα, H4 acetylation analysis, trypsin/chymotrypsin inhibitor treatment, IκBα deletion in intestinal organoids","journal":"EMBO Reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus co-IP with mutants and functional differentiation assay; single lab, multiple orthogonal methods","pmids":["34224210"],"is_preprint":false},{"year":2023,"finding":"USP39 deubiquitinating enzyme interacts with IκBα and removes K48-linked polyubiquitin chains, stabilizing basal IκBα and suppressing NF-κB-mediated inflammatory responses; USP39 knockdown/knockout in macrophages increases pro-inflammatory cytokine secretion; USP39-defective mice are more sensitive to LPS-induced sepsis.","method":"Co-immunoprecipitation, USP39 siRNA/CRISPR knockout, K48-linked ubiquitination assay, LPS stimulation, in vivo sepsis model","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus ubiquitination assay plus in vivo model; single lab","pmids":["36651806"],"is_preprint":false},{"year":2015,"finding":"Nuclear import rate, nuclear export rate of free IκBα, and the half-life of free IκBα are identified as critical determinants of post-induction NF-κB repression and the potential for NF-κB re-activation; NF-κB-inducible expression of IκBα alone is not sufficient for effective negative feedback—the biophysical properties of IκBα nuclear transport are also required.","method":"Computational modeling of NF-κB signaling, single-cell live imaging, biochemical half-life measurements, nuclear import/export perturbation experiments","journal":"Journal of the Royal Society Interface","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — computational predictions tested with live single-cell imaging and biochemical experiments; single lab","pmids":["26311312"],"is_preprint":false},{"year":2001,"finding":"IκBα differentially regulates NF-κB subunit nuclear localization in a subunit composition-dependent manner: IκBα binding attenuates nuclear import potential of p65 and c-Rel homodimers but not p50-associated heterodimers, leading to a greater propensity of heterodimers to reside in the nucleus; c-Rel-IκBα complexes in mature B cells result in nuclear c-Rel accumulation following IκBα turnover and shuttling.","method":"Nuclear import assays, NLS mutagenesis, subcellular fractionation, nuclear export assay (CRM1 dependence), co-immunoprecipitation in B-cell lines","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — nuclear transport assays combined with fractionation and co-IP; single lab, multiple approaches","pmids":["11416157"],"is_preprint":false},{"year":2025,"finding":"N4BP3 interacts with IκBα and promotes K48-linked ubiquitination of IκBα, leading to NF-κB pathway activation; N4BP3 overexpression elevates K48-linked ubiquitination of IκBα and increases pro-inflammatory cytokine expression in THP-1 cells, whereas N4BP3 knockdown reduces IκBα ubiquitination and colitis severity in vivo.","method":"Co-immunoprecipitation, K48-linked ubiquitination assay, N4BP3 overexpression/knockdown, DSS-induced colitis mouse model, AAV-mediated knockdown","journal":"Journal of Inflammation Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with ubiquitination assay plus in vivo model; single lab","pmids":["40487287"],"is_preprint":false},{"year":2022,"finding":"TRIM67 competes with IκBα for binding to β-TrCP, thereby inhibiting β-TrCP-mediated ubiquitination and degradation of IκBα and suppressing TNFα-triggered NF-κB activation; Trim67 deletion in MEFs promotes inflammatory gene expression after TNFα.","method":"Co-immunoprecipitation (TRIM67–β-TrCP–IκBα competition), Trim67 knockdown/knockout, TNFα stimulation assays, NF-κB reporter","journal":"Frontiers in Immunology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — co-IP competition assay plus genetic knockout; single lab","pmids":["35273593"],"is_preprint":false},{"year":2017,"finding":"FBXO32 F-box protein stabilizes and polyubiquitinates IκBα under genotoxic stress and inflammatory conditions, promoting proteasomal degradation of IκBα and NF-κB activation; FBXO32 also regulates basal IκBα levels in unstressed cells.","method":"Co-immunoprecipitation, ubiquitination assay, FBXO32 overexpression/knockdown, genotoxic stress (doxorubicin) and LPS treatment","journal":"The International Journal of Biochemistry & Cell Biology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, co-IP and ubiquitination assay without detailed domain mapping or in vitro reconstitution","pmids":["28970077"],"is_preprint":false},{"year":1998,"finding":"IκBα contains distinct functional domains for cytoplasmic versus nuclear regulation of c-Rel: the N-terminal and central ankyrin regions mediate cytoplasmic retention and NLS masking, while the central ankyrin domain and negatively charged residues in the C-terminal PEST domain are required for nuclear regulation of c-Rel.","method":"Domain-deletion mutagenesis of IκBα, subcellular fractionation, transcriptional reporter assays","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic deletion mapping with functional readouts; single lab, multiple domain constructs","pmids":["9488436"],"is_preprint":false},{"year":2003,"finding":"IκBα cytoplasmic sequestration of p65 is sufficient to translocate nuclear corepressors N-CoR/SMRT to the cytoplasm and upregulate Notch-dependent transcription; p65 and IκBα can directly bind SMRT, and this interaction is inhibited by CBP/p300 coactivator in a dose-dependent manner and by TNFα treatment, suggesting p65 acetylation modulates this cross-talk.","method":"Co-immunoprecipitation (p65–IκBα–SMRT), subcellular fractionation, reporter assays, TNFα stimulation","journal":"Molecular Biology of the Cell","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — co-IP of trimeric complex plus functional reporter with competitor experiments; single lab","pmids":["12589049"],"is_preprint":false},{"year":1999,"finding":"Purified protein kinase CKII directly phosphorylates IκBα at both S32 and S36 in vitro, and CKII immunoprecipitated from cells specifically associates with IκBα; this CKII kinase activity is biochemically distinct from the IKKα/β-containing signalsome complex.","method":"In vitro phosphorylation assay with purified CKII, immunoprecipitation of endogenous CKII-IκBα complex, phospho-site mapping","journal":"Journal of Molecular Biology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay plus in vivo co-IP; single lab","pmids":["10398585"],"is_preprint":false},{"year":2014,"finding":"COMMD1/Murr1 stabilizes IκBα protein by increasing its interaction with IκBα and inhibiting proteasomal degradation in latently HIV-1-infected myeloid cells; COMMD1 induction by the PI3K-JAK pathway attenuates NF-κB signaling and enhances HIV-1 latency.","method":"Co-immunoprecipitation (COMMD1–IκBα), proteasome inhibitor assays, PI3K-JAK pathway inhibitors, Western blot in matched parental/latently infected cell lines","journal":"Journal of Virology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — co-IP plus pharmacological dissection; single lab, cell-line-based study","pmids":["25520503"],"is_preprint":false},{"year":2011,"finding":"Dimethylfumarate (DMF) reduces intracellular glutathione and induces glutathionylation of IκBα (IκBα-SSG), which inhibits IκBα degradation, NF-κB p65 nuclear entry, and NF-κB/DNA binding in airway smooth muscle cells; these effects are reversed by addition of GSH-OEt, confirming glutathionylation as the inhibitory modification.","method":"Co-immunoprecipitation of glutathionylated IκBα, EMSA (NF-κB/DNA binding), immunofluorescence, Western blot, GSH-OEt rescue","journal":"The European Respiratory Journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct detection of IκBα-SSG plus functional rescue experiment; single lab, multiple readouts","pmids":["21719482"],"is_preprint":false},{"year":2002,"finding":"PPARα activation potentiates p65-stimulated IκBα transcription in a ligand-dependent manner requiring the NF-κB and Sp1 sites in the IκBα promoter; this mechanism requires the coactivator DRIP205 but not CBP/p300; ChIP assays show PPARα activation enhances occupancy of the NF-κB response element in the IκBα promoter in vivo.","method":"Transient transfection luciferase assays, site-directed mutagenesis of NF-κB/Sp1 promoter sites, chromatin immunoprecipitation, dominant-negative DRIP205 overexpression","journal":"Molecular Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter mutagenesis plus ChIP plus dominant-negative; single lab","pmids":["11981037"],"is_preprint":false},{"year":2009,"finding":"Nur77 (orphan nuclear receptor) directly binds to a Nur77 response element in the IκBα promoter and transcriptionally upregulates IκBα expression; Nur77 overexpression increases IκBα protein ~4-fold, whereas dominant-negative Nur77 (lacking transactivation domain) has no effect; the resulting IκBα upregulation suppresses TNFα- and IL-1β-induced NF-κB activation and endothelial cell adhesion molecule expression.","method":"Adenoviral overexpression, dominant-negative Nur77, IκBα promoter-reporter assay, ChIP (Nur77 binding to IκBα promoter), Western blot, NF-κB activation assays","journal":"Circulation Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus promoter-reporter with dominant-negative validation; single lab","pmids":["19213954"],"is_preprint":false},{"year":2008,"finding":"Tumor suppressor SMAR1 binds directly to the matrix attachment region (MAR) site in the IκBα promoter, recruits a corepressor complex, and represses IκBα transcription; this generates NF-κB complexes (p65-p50) that are DNA-binding competent but phosphorylation- and transactivation-deficient, suppressing a subset of NF-κB target genes involved in tumorigenesis.","method":"ChIP (SMAR1 binding to IκBα promoter MAR site), promoter-reporter assay, SMAR1 overexpression/siRNA, NF-κB target gene array","journal":"The Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with functional reporter and gene array; single lab","pmids":["18981184"],"is_preprint":false}],"current_model":"IκBα (NFKBIA) sequesters NF-κB dimers in the cytoplasm by masking the p65 NLS with its ankyrin repeats (crystal structure established) and occluding the DNA-binding cleft; upon inflammatory stimulation, IKK phosphorylates IκBα at S32/S36 (or GRK6/CKII can also phosphorylate these sites), triggering K48-linked polyubiquitination by SCFβ-TrCP and proteasomal degradation that is facilitated post-ubiquitinationally by the p97-UFD1L-NPL4 complex; free IκBα is also degraded constitutively via a ubiquitin-independent, PEST-domain-dependent proteasomal pathway; additional non-canonical degradation routes include calpain-mediated cleavage (promoted by CK2 PEST-domain phosphorylation or HK2-mediated T291 phosphorylation), an IKK-independent DNA-damage pathway, and tyrosine nitration (Y181) by radiation-induced NO; the degradation of IκBα is counteracted by multiple deubiquitinases (USP39, USP9X) and E3 competitors (TRIM67 competing with β-TrCP), and is enhanced by additional E3 ligases (TRIM22, Bmi1, FBXO32, N4BP3, ROC1); free IκBα is actively imported into the nucleus via importin α/β and its ankyrin repeats, where it can strip NF-κB from DNA (allosterically twisting the heterodimer) and export it via CRM1 facilitated by 14-3-3 proteins; NFKBIA transcription itself is a major NF-κB target providing negative feedback, and this feedback is further regulated epigenetically by KDM5B-mediated H3K4me3 erasure or by SMAR1/Nur77/PPARα binding to the IκBα promoter; phosphorylated IκBα also binds chromatin (histones H2A/H4) in a manner regulated by H4 acetylation, contributing to intestinal differentiation, and IκBα transiently localizes to mitochondria under hypoxia in a ROS/STAT3-dependent manner."},"narrative":{"mechanistic_narrative":"IκBα (NFKBIA) is the principal cytoplasmic inhibitor of NF-κB, governing the inducibility and dynamics of NF-κB-dependent transcription in inflammation, development, and tumorigenesis [PMID:9865693, PMID:8631829]. Its ankyrin repeat domain clamps the C-terminal Rel homology regions of the p50/p65 heterodimer, masking the p65 nuclear localization signal and occluding the DNA-binding cleft so the dimer is retained in an inactive cytoplasmic state [PMID:9865693]; binding is governed by coupled folding of ankyrin repeats 5–6, such that incomplete folding weakens NF-κB capture and compromises inhibition [PMID:18511071]. Upon inflammatory signaling, IκBα is phosphorylated at S32/S36 — by IKK and additionally by CKII and GRK6 — which licenses recognition by the SCF^β-TrCP E3 ligase, K48-linked polyubiquitination, and proteasomal degradation, an obligatory order in which phosphorylation precedes ubiquitination [PMID:8631829, PMID:9859996, PMID:10398585, PMID:25881508]; the p97-UFD1L-NPL4 ATPase complex acts post-ubiquitinationally to drive efficient proteolysis [PMID:24248593]. IκBα turnover is dual: free IκBα is degraded rapidly through a ubiquitin-independent, PEST-dependent proteasomal route, whereas NF-κB-bound IκBα masks the PEST domain and is degraded slowly via the phosphorylation/ubiquitination route [PMID:18401342]. Multiple non-canonical routes also dismantle the inhibitor — CK2- or HK2(T291)-primed calpain cleavage, an IKK-independent genotoxic-stress pathway, and tyrosine-181 nitration that dissociates intact IκBα from NF-κB without proteolysis [PMID:11673497, PMID:36007522, PMID:14585967, PMID:17910475]. Beyond cytoplasmic sequestration, free IκBα is actively imported into the nucleus via its ankyrin repeats and importin α/β, where it strips NF-κB from DNA through long-range allosteric twisting of the heterodimer and exports it via CRM1 with 14-3-3 assistance, making nuclear transport kinetics a determinant of post-induction repression and re-activation [PMID:10037782, PMID:28249778, PMID:16931600, PMID:26311312]. NFKBIA is itself an NF-κB-inducible negative-feedback gene whose output is tuned epigenetically and transcriptionally, including KDM5B-mediated erasure of H3K4me3 at the promoter to permit full NF-κB activation [PMID:36914768]. Phosphorylated IκBα additionally associates with nucleosomes via histones H2A/H4 in an H4-acetylation-dependent manner, contributing to intestinal epithelial differentiation [PMID:34224210].","teleology":[{"year":1996,"claim":"Established the causal order of the canonical degradation switch — that signal-induced phosphorylation of IκBα is a prerequisite for its inducible ubiquitination and proteasomal destruction.","evidence":"TNFα stimulation with proteasome inhibition, anti-ubiquitin IP, and an S32A/S36A non-phosphorylatable mutant","pmids":["8631829"],"confidence":"High","gaps":["Did not identify the E3 ligase that reads the phosphodegron","Did not resolve the kinase responsible in vivo"]},{"year":1998,"claim":"Defined the structural basis of NF-κB inhibition, showing how ankyrin repeats mask the p65 NLS and occlude the DNA-binding cleft.","evidence":"2.7 Å X-ray crystal structure of the IκBα ankyrin domain bound to a truncated p50/p65 heterodimer","pmids":["9865693"],"confidence":"High","gaps":["Truncated NF-κB lacked full-length context","Did not capture the molecular-stripping transition state"]},{"year":1998,"claim":"Identified β-TrCP as the substrate-recognition receptor that reads phospho-IκBα, completing the canonical phospho-ubiquitin module.","evidence":"Immunoaffinity purification with MS identification, in vitro reconstituted ubiquitination, and dominant-negative F-box mutant in vivo","pmids":["9859996"],"confidence":"High","gaps":["Did not address post-ubiquitination handoff to the proteasome","Did not address basal versus induced turnover"]},{"year":1999,"claim":"Showed that free IκBα is not merely a static cytoplasmic anchor but is actively imported into the nucleus, establishing nuclear shuttling as part of its regulatory repertoire.","evidence":"Import assays in digitonin-permeabilized cells with importin α/β/Ran dependence and ankyrin-repeat competition","pmids":["10037782"],"confidence":"High","gaps":["Identity of the ankyrin-recognizing import factor not resolved","Functional consequence of nuclear IκBα not yet shown"]},{"year":1999,"claim":"Demonstrated that S32/S36 phosphorylation is not exclusive to IKK, with CKII directly modifying the same sites, broadening the kinase input.","evidence":"In vitro kinase assay with purified CKII and co-IP of endogenous CKII-IκBα","pmids":["10398585"],"confidence":"Medium","gaps":["Physiological signal triggering CKII phosphorylation unclear","Relative contribution versus IKK in vivo not quantified"]},{"year":2001,"claim":"Uncovered a non-canonical, calpain-dependent destruction route primed by CK2 phosphorylation of PEST-domain residues, distinct from the proteasomal pathway.","evidence":"In vitro CK2 phosphorylation/calpain degradation with an S283A/T291A/T299A mutant in IgM+ B cells","pmids":["11673497"],"confidence":"High","gaps":["Physiological signal coupling CK2 to calpain not defined","Generality beyond B cells unaddressed"]},{"year":2003,"claim":"Showed NF-κB can be activated through IKK-independent, phosphorylation- and PEST-independent IκBα degradation under genotoxic stress, revealing pathway redundancy.","evidence":"IKK1/2-double-knockout MEFs with doxorubicin, phospho-mutant IκBα, PI3K and proteasome inhibitors, chromatin reporter","pmids":["14585967"],"confidence":"High","gaps":["E3 ligase for this route not identified here","Degron recognized in absence of S32/S36 unknown"]},{"year":2006,"claim":"Identified 14-3-3 as an obligate partner for CRM1-dependent nuclear export of p65-IκBα complexes, linking export machinery to NF-κB termination.","evidence":"Reciprocal co-IP, domain mapping, dominant-negative 14-3-3, and ChIP","pmids":["16931600"],"confidence":"High","gaps":["Whether 14-3-3 binding is phospho-regulated not resolved","Stoichiometry of the export complex undetermined"]},{"year":2008,"claim":"Resolved two kinetically distinct degradation pathways and showed NF-κB binding protects IκBα by masking its PEST domain, explaining how free versus bound pools are differentially controlled.","evidence":"Biochemical fractionation, proteasome and ubiquitination assays, PEST-domain mutants, protein half-life measurements","pmids":["18401342"],"confidence":"High","gaps":["Proteasomal recognition of free PEST not structurally defined","In vivo balance of the two pools not quantified"]},{"year":2008,"claim":"Demonstrated that coupled folding-and-binding of ankyrin repeats 5–6 is functionally required, linking IκBα conformational dynamics to the strength of NF-κB inhibition and to its own turnover rate.","evidence":"Stabilizing AR5-6 mutagenesis with SPR, ITC, co-IP, and pulse-chase half-life assays","pmids":["18511071"],"confidence":"High","gaps":["In vivo signaling consequences only inferred from cell assays","Folding intermediates not structurally characterized"]},{"year":2017,"claim":"Provided the biophysical mechanism of molecular stripping, showing IκBα allosterically destabilizes the DNA-bound state to actively remove NF-κB from DNA.","evidence":"HDX-MS coupled with coarse-grained molecular dynamics simulations","pmids":["28249778"],"confidence":"Medium","gaps":["No mutagenesis confirmation of the specific repulsive contacts","Kinetics in living cells not measured"]},{"year":null,"claim":"The full set of E3 ligases, deubiquitinases, kinases, and metabolic enzymes reported to converge on IκBα has not been reconciled into a quantitative model of when each route dominates in a given cell type or stimulus.","evidence":"","pmids":[],"confidence":"Low","gaps":["Many regulators (e.g. TRIM22, N4BP3, FBXO32, USP14/USP39, HK2, FBP1) rest on single-lab co-IP/functional studies without in vitro reconstitution","Cell-type and stimulus specificity of canonical versus non-canonical degradation unresolved","Interplay between nuclear stripping, chromatin binding, and feedback transcription not integrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,10,14]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[0,4,14]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[27]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3,4,5]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,8,30]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[26]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[27]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,2,1]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[16,28,21]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[2,3,12]}],"complexes":["NF-κB/IκBα (p50/p65) complex","SCF^β-TrCP ubiquitin ligase"],"partners":["RELA","NFKB1","BTRC","YWHA (14-3-3)","G3BP2","RPS3","VCP (P97)","TRIM67"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P25963","full_name":"NF-kappa-B inhibitor alpha","aliases":["I-kappa-B-alpha","IkB-alpha","IkappaBalpha","Major histocompatibility complex enhancer-binding protein MAD3"],"length_aa":317,"mass_kda":35.6,"function":"Inhibits the activity of dimeric NF-kappa-B/REL complexes by trapping REL (RELA/p65 and NFKB1/p50) dimers in the cytoplasm by masking their nuclear localization signals (PubMed:1493333, PubMed:36651806, PubMed:7479976). On cellular stimulation by immune and pro-inflammatory responses, becomes phosphorylated promoting ubiquitination and degradation, enabling the dimeric RELA to translocate to the nucleus and activate transcription (PubMed:7479976, PubMed:7628694, PubMed:7796813, PubMed:7878466)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/P25963/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NFKBIA","classification":"Not Classified","n_dependent_lines":58,"n_total_lines":1208,"dependency_fraction":0.048013245033112585},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"NFKB1","stoichiometry":10.0},{"gene":"RELA","stoichiometry":10.0},{"gene":"MDH1","stoichiometry":0.2},{"gene":"NFKB2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/NFKBIA","total_profiled":1310},"omim":[{"mim_id":"621029","title":"RING FINGER PROTEIN 183; RNF183","url":"https://www.omim.org/entry/621029"},{"mim_id":"620529","title":"RING FINGER PROTEIN 121; RNF121","url":"https://www.omim.org/entry/620529"},{"mim_id":"619265","title":"TRIPARTITE MOTIF-CONTAINING PROTEIN 52; TRIM52","url":"https://www.omim.org/entry/619265"},{"mim_id":"619105","title":"MICRO RNA 30E; MIR30E","url":"https://www.omim.org/entry/619105"},{"mim_id":"618536","title":"CACTIN, SPLICEOSOME C COMPLEX SUBUNIT; CACTIN","url":"https://www.omim.org/entry/618536"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Cytosol","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":960.5}],"url":"https://www.proteinatlas.org/search/NFKBIA"},"hgnc":{"alias_symbol":["IKBA","MAD-3","IkappaBalpha"],"prev_symbol":["NFKBI"]},"alphafold":{"accession":"P25963","domains":[{"cath_id":"1.25.40.20","chopping":"69-170","consensus_level":"medium","plddt":95.9362,"start":69,"end":170}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P25963","model_url":"https://alphafold.ebi.ac.uk/files/AF-P25963-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P25963-F1-predicted_aligned_error_v6.png","plddt_mean":83.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NFKBIA","jax_strain_url":"https://www.jax.org/strain/search?query=NFKBIA"},"sequence":{"accession":"P25963","fasta_url":"https://rest.uniprot.org/uniprotkb/P25963.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P25963/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P25963"}},"corpus_meta":[{"pmid":"9865693","id":"PMC_9865693","title":"Structure of an IkappaBalpha/NF-kappaB complex.","date":"1998","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9865693","citation_count":713,"is_preprint":false},{"pmid":"9859996","id":"PMC_9859996","title":"Identification of the receptor component of the IkappaBalpha-ubiquitin ligase.","date":"1998","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9859996","citation_count":567,"is_preprint":false},{"pmid":"36007522","id":"PMC_36007522","title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα.","date":"2022","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/36007522","citation_count":350,"is_preprint":false},{"pmid":"21734245","id":"PMC_21734245","title":"Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.","date":"2011","source":"Clinical microbiology reviews","url":"https://pubmed.ncbi.nlm.nih.gov/21734245","citation_count":294,"is_preprint":false},{"pmid":"10340377","id":"PMC_10340377","title":"Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10340377","citation_count":264,"is_preprint":false},{"pmid":"8631829","id":"PMC_8631829","title":"Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8631829","citation_count":210,"is_preprint":false},{"pmid":"21175304","id":"PMC_21175304","title":"NFKBIA deletion in glioblastomas.","date":"2010","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21175304","citation_count":204,"is_preprint":false},{"pmid":"15322087","id":"PMC_15322087","title":"Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15322087","citation_count":177,"is_preprint":false},{"pmid":"18401342","id":"PMC_18401342","title":"NF-kappaB dictates the degradation pathway of IkappaBalpha.","date":"2008","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/18401342","citation_count":174,"is_preprint":false},{"pmid":"17701919","id":"PMC_17701919","title":"NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases.","date":"2007","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/17701919","citation_count":162,"is_preprint":false},{"pmid":"14585967","id":"PMC_14585967","title":"IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14585967","citation_count":135,"is_preprint":false},{"pmid":"32814880","id":"PMC_32814880","title":"TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.","date":"2020","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/32814880","citation_count":129,"is_preprint":false},{"pmid":"31455356","id":"PMC_31455356","title":"Curcumin attenuates MSU crystal-induced inflammation by inhibiting the degradation of IκBα and blocking mitochondrial damage.","date":"2019","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31455356","citation_count":124,"is_preprint":false},{"pmid":"20055496","id":"PMC_20055496","title":"Molecular mechanisms of system control of NF-kappaB signaling by IkappaBalpha.","date":"2010","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20055496","citation_count":119,"is_preprint":false},{"pmid":"19213954","id":"PMC_19213954","title":"The orphan nuclear receptor Nur77 suppresses endothelial cell activation through induction of IkappaBalpha expression.","date":"2009","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/19213954","citation_count":112,"is_preprint":false},{"pmid":"15337789","id":"PMC_15337789","title":"The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes.","date":"2004","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15337789","citation_count":102,"is_preprint":false},{"pmid":"10037782","id":"PMC_10037782","title":"Characterization of IkappaBalpha nuclear import pathway.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10037782","citation_count":99,"is_preprint":false},{"pmid":"10969074","id":"PMC_10969074","title":"IkappaBalpha and IkappaBalpha /NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10969074","citation_count":99,"is_preprint":false},{"pmid":"11981037","id":"PMC_11981037","title":"DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha.","date":"2002","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/11981037","citation_count":98,"is_preprint":false},{"pmid":"11673497","id":"PMC_11673497","title":"Phosphorylation by the protein kinase CK2 promotes calpain-mediated degradation of IkappaBalpha.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11673497","citation_count":93,"is_preprint":false},{"pmid":"12589049","id":"PMC_12589049","title":"IkappaBalpha and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFkappaB pathways.","date":"2003","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12589049","citation_count":83,"is_preprint":false},{"pmid":"20396415","id":"PMC_20396415","title":"Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages.","date":"2010","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/20396415","citation_count":80,"is_preprint":false},{"pmid":"17910475","id":"PMC_17910475","title":"Tyrosine nitration of IkappaBalpha: a novel mechanism for NF-kappaB activation.","date":"2007","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17910475","citation_count":80,"is_preprint":false},{"pmid":"11295496","id":"PMC_11295496","title":"Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway.","date":"2001","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/11295496","citation_count":79,"is_preprint":false},{"pmid":"34051264","id":"PMC_34051264","title":"Exosome-based delivery of super-repressor IκBα ameliorates kidney ischemia-reperfusion injury.","date":"2021","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/34051264","citation_count":79,"is_preprint":false},{"pmid":"25887954","id":"PMC_25887954","title":"β₁-adrenoceptor stimulation promotes LPS-induced cardiomyocyte apoptosis through activating PKA and enhancing CaMKII and IκBα phosphorylation.","date":"2015","source":"Critical care (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25887954","citation_count":74,"is_preprint":false},{"pmid":"18412279","id":"PMC_18412279","title":"A novel mutation in NFKBIA/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency.","date":"2008","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/18412279","citation_count":67,"is_preprint":false},{"pmid":"23487427","id":"PMC_23487427","title":"Functional genetic variation in NFKBIA and susceptibility to childhood asthma, bronchiolitis, and bronchopulmonary dysplasia.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23487427","citation_count":64,"is_preprint":false},{"pmid":"12406554","id":"PMC_12406554","title":"Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer.","date":"2002","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/12406554","citation_count":64,"is_preprint":false},{"pmid":"33459422","id":"PMC_33459422","title":"Transcriptional repression of NFKBIA triggers constitutive IKK- and proteasome-independent p65/RelA activation in senescence.","date":"2021","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/33459422","citation_count":63,"is_preprint":false},{"pmid":"30621631","id":"PMC_30621631","title":"miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.","date":"2019","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30621631","citation_count":59,"is_preprint":false},{"pmid":"33224945","id":"PMC_33224945","title":"Post-translational Modifications of IκBα: The State of the Art.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33224945","citation_count":58,"is_preprint":false},{"pmid":"16931600","id":"PMC_16931600","title":"Efficient nuclear export of p65-IkappaBalpha complexes requires 14-3-3 proteins.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16931600","citation_count":57,"is_preprint":false},{"pmid":"29512862","id":"PMC_29512862","title":"MicroRNA-216a induces endothelial senescence and inflammation via Smad3/IκBα pathway.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29512862","citation_count":55,"is_preprint":false},{"pmid":"23284737","id":"PMC_23284737","title":"Heterologous SUMO-2/3-ubiquitin chains optimize IκBα degradation and NF-κB activity.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23284737","citation_count":54,"is_preprint":false},{"pmid":"22509384","id":"PMC_22509384","title":"Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22509384","citation_count":54,"is_preprint":false},{"pmid":"35180863","id":"PMC_35180863","title":"Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription.","date":"2022","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/35180863","citation_count":51,"is_preprint":false},{"pmid":"28597146","id":"PMC_28597146","title":"Human IκBα Gain of Function: a Severe and Syndromic Immunodeficiency.","date":"2017","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28597146","citation_count":49,"is_preprint":false},{"pmid":"18511071","id":"PMC_18511071","title":"Pre-folding IkappaBalpha alters control of NF-kappaB signaling.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18511071","citation_count":49,"is_preprint":false},{"pmid":"23708964","id":"PMC_23708964","title":"A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathy.","date":"2013","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23708964","citation_count":47,"is_preprint":false},{"pmid":"1427874","id":"PMC_1427874","title":"Chromosomal localization of the genes encoding the p50/p105 subunits of NF-kappa B (NFKB2) and the I kappa B/MAD-3 (NFKBI) inhibitor of NF-kappa B to 4q24 and 14q13, respectively.","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1427874","citation_count":44,"is_preprint":false},{"pmid":"40487287","id":"PMC_40487287","title":"N4BP3 Activates TLR4-NF-κB Pathway in Inflammatory Bowel Disease by Promoting K48-Linked IκBα Ubiquitination.","date":"2025","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/40487287","citation_count":44,"is_preprint":false},{"pmid":"35273593","id":"PMC_35273593","title":"TRIM67 Suppresses TNFalpha-Triggered NF-kB Activation by Competitively Binding Beta-TrCP to IkBa.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35273593","citation_count":39,"is_preprint":false},{"pmid":"30550885","id":"PMC_30550885","title":"USP14-mediated IκBα degradation exacerbates NF-κB activation and IL-1β-stimulated chondrocyte dedifferentiation.","date":"2018","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30550885","citation_count":39,"is_preprint":false},{"pmid":"24248593","id":"PMC_24248593","title":"The p97-UFD1L-NPL4 protein complex mediates cytokine-induced IκBα proteolysis.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24248593","citation_count":39,"is_preprint":false},{"pmid":"33962660","id":"PMC_33962660","title":"ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/33962660","citation_count":38,"is_preprint":false},{"pmid":"36914768","id":"PMC_36914768","title":"Histone demethylase KDM5B licenses macrophage-mediated inflammatory responses by repressing Nfkbia transcription.","date":"2023","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/36914768","citation_count":38,"is_preprint":false},{"pmid":"8666399","id":"PMC_8666399","title":"Structure and evolution of the human IKBA gene.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8666399","citation_count":38,"is_preprint":false},{"pmid":"36375245","id":"PMC_36375245","title":"Baicalin regulates TLR4/IκBα/NFκB signaling pathway to alleviate inflammation in Doxorubicin related cardiotoxicity.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36375245","citation_count":38,"is_preprint":false},{"pmid":"23457512","id":"PMC_23457512","title":"Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23457512","citation_count":38,"is_preprint":false},{"pmid":"21719482","id":"PMC_21719482","title":"IκBα glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES.","date":"2011","source":"The European respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/21719482","citation_count":36,"is_preprint":false},{"pmid":"11416157","id":"PMC_11416157","title":"Cell-specific association and shuttling of IkappaBalpha provides a mechanism for nuclear NF-kappaB in B lymphocytes.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11416157","citation_count":36,"is_preprint":false},{"pmid":"32026471","id":"PMC_32026471","title":"circ-CEP85L suppresses the proliferation and invasion of gastric cancer by regulating NFKBIA expression via miR-942-5p.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32026471","citation_count":34,"is_preprint":false},{"pmid":"19438714","id":"PMC_19438714","title":"The IkappaBalpha gene is a peroxisome proliferator-activated receptor cardiac target gene.","date":"2009","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/19438714","citation_count":32,"is_preprint":false},{"pmid":"30902734","id":"PMC_30902734","title":"Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease.","date":"2019","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/30902734","citation_count":32,"is_preprint":false},{"pmid":"36646759","id":"PMC_36646759","title":"Fructose-1,6-bisphosphatase 1 dephosphorylates IκBα and suppresses colorectal tumorigenesis.","date":"2023","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/36646759","citation_count":31,"is_preprint":false},{"pmid":"10398585","id":"PMC_10398585","title":"Serine 32 and serine 36 of IkappaBalpha are directly phosphorylated by protein kinase CKII in vitro.","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10398585","citation_count":31,"is_preprint":false},{"pmid":"26311312","id":"PMC_26311312","title":"Anatomy of a negative feedback loop: the case of IκBα.","date":"2015","source":"Journal of the Royal Society, Interface","url":"https://pubmed.ncbi.nlm.nih.gov/26311312","citation_count":30,"is_preprint":false},{"pmid":"21156791","id":"PMC_21156791","title":"Fibromodulin suppresses nuclear factor-kappaB activity by inducing the delayed degradation of IKBA via a JNK-dependent pathway coupled to fibroblast apoptosis.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21156791","citation_count":29,"is_preprint":false},{"pmid":"32770227","id":"PMC_32770227","title":"Histone deacetylase 4 inhibits NF-κB activation by facilitating IκBα sumoylation.","date":"2020","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32770227","citation_count":29,"is_preprint":false},{"pmid":"7983736","id":"PMC_7983736","title":"The relocalization of v-Rel from the nucleus to the cytoplasm coincides with induction of expression of Ikba and nfkb1 and stabilization of I kappa B-alpha.","date":"1995","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/7983736","citation_count":28,"is_preprint":false},{"pmid":"28249778","id":"PMC_28249778","title":"DNA and IκBα Both Induce Long-Range Conformational Changes in NFκB.","date":"2017","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28249778","citation_count":27,"is_preprint":false},{"pmid":"36651806","id":"PMC_36651806","title":"USP39 Regulates NF-κB-Mediated Inflammatory Responses through Deubiquitinating K48-Linked IκBα.","date":"2023","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/36651806","citation_count":26,"is_preprint":false},{"pmid":"24578542","id":"PMC_24578542","title":"Genetic polymorphism of NFKB1 and NFKBIA genes and liver cancer risk: a nested case-control study in Shanghai, China.","date":"2014","source":"BMJ open","url":"https://pubmed.ncbi.nlm.nih.gov/24578542","citation_count":26,"is_preprint":false},{"pmid":"19816602","id":"PMC_19816602","title":"Suppression of IkappaBalpha increases the expression of matrix metalloproteinase-2 in human ciliary muscle cells.","date":"2009","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/19816602","citation_count":26,"is_preprint":false},{"pmid":"26075620","id":"PMC_26075620","title":"Genetic Variation in NFKB1 and NFKBIA and Susceptibility to Coronary Artery Disease in a Chinese Uygur Population.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26075620","citation_count":25,"is_preprint":false},{"pmid":"20193848","id":"PMC_20193848","title":"Mutations of NFKBIA in biopsy specimens from Hodgkin lymphoma.","date":"2010","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/20193848","citation_count":25,"is_preprint":false},{"pmid":"20495844","id":"PMC_20495844","title":"Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.","date":"2010","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/20495844","citation_count":24,"is_preprint":false},{"pmid":"28670959","id":"PMC_28670959","title":"Association of NFKB1 and NFKBIA gene polymorphisms with susceptibility of gastric cancer.","date":"2017","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28670959","citation_count":24,"is_preprint":false},{"pmid":"31612070","id":"PMC_31612070","title":"Genetic Association between NFKBIA and NFKB1 Gene Polymorphisms and the Susceptibility to Head and Neck Cancer: A Meta-Analysis.","date":"2019","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/31612070","citation_count":23,"is_preprint":false},{"pmid":"17568818","id":"PMC_17568818","title":"Deguelin inhibits expression of IkappaBalpha protein and induces apoptosis of B-CLL cells in vitro.","date":"2007","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/17568818","citation_count":23,"is_preprint":false},{"pmid":"16207380","id":"PMC_16207380","title":"Regulation of IkappaBalpha expression involves both NF-kappaB and the MAP kinase signaling pathways.","date":"2005","source":"Journal of inflammation (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16207380","citation_count":23,"is_preprint":false},{"pmid":"24457201","id":"PMC_24457201","title":"Ribosomal protein S3 interacts with the NF-κB inhibitor IκBα.","date":"2014","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/24457201","citation_count":22,"is_preprint":false},{"pmid":"9488436","id":"PMC_9488436","title":"Distinct domains of IkappaBalpha regulate c-Rel in the cytoplasm and in the nucleus.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9488436","citation_count":22,"is_preprint":false},{"pmid":"9794238","id":"PMC_9794238","title":"Relationship between IkappaBalpha constitutive expression, TNFalpha synthesis, and apoptosis in EBV-infected lymphoblastoid cells.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9794238","citation_count":22,"is_preprint":false},{"pmid":"17355202","id":"PMC_17355202","title":"A cell-based assay for IkappaBalpha stabilization using a two-color dual luciferase-based sensor.","date":"2007","source":"Assay and drug development technologies","url":"https://pubmed.ncbi.nlm.nih.gov/17355202","citation_count":22,"is_preprint":false},{"pmid":"32750042","id":"PMC_32750042","title":"Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency.","date":"2020","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/32750042","citation_count":21,"is_preprint":false},{"pmid":"34855159","id":"PMC_34855159","title":"SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α.","date":"2021","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/34855159","citation_count":21,"is_preprint":false},{"pmid":"18981184","id":"PMC_18981184","title":"Tumor suppressor SMAR1 represses IkappaBalpha expression and inhibits p65 transactivation through matrix attachment regions.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18981184","citation_count":21,"is_preprint":false},{"pmid":"30604211","id":"PMC_30604211","title":"Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.","date":"2019","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/30604211","citation_count":21,"is_preprint":false},{"pmid":"26488500","id":"PMC_26488500","title":"Common Polymorphisms in the NFKBIA Gene and Cancer Susceptibility: A Meta-Analysis.","date":"2015","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/26488500","citation_count":20,"is_preprint":false},{"pmid":"25881508","id":"PMC_25881508","title":"GRK6 phosphorylates IκBα at Ser(32)/Ser(36) and enhances TNF-α-induced inflammation.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25881508","citation_count":20,"is_preprint":false},{"pmid":"30209188","id":"PMC_30209188","title":"Bmi1 Regulates IκBα Degradation via Association with the SCF Complex.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30209188","citation_count":20,"is_preprint":false},{"pmid":"30619291","id":"PMC_30619291","title":"β-TrCP Restricts Lipopolysaccharide (LPS)-Induced Activation of TRAF6-IKK Pathway Upstream of IκBα Signaling.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30619291","citation_count":20,"is_preprint":false},{"pmid":"26463447","id":"PMC_26463447","title":"p97/VCP promotes Cullin-RING-ubiquitin-ligase/proteasome-dependent degradation of IκBα and the preceding liberation of RelA from ubiquitinated IκBα.","date":"2015","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26463447","citation_count":20,"is_preprint":false},{"pmid":"36912495","id":"PMC_36912495","title":"Exosomal miR-196a-5p enhances radioresistance in lung cancer cells by downregulating NFKBIA.","date":"2023","source":"The Kaohsiung journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36912495","citation_count":19,"is_preprint":false},{"pmid":"31484794","id":"PMC_31484794","title":"Hypoxia induces rapid, STAT3 and ROS dependent, mitochondrial translocation of RelA(p65) and IκBα.","date":"2019","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/31484794","citation_count":19,"is_preprint":false},{"pmid":"10199915","id":"PMC_10199915","title":"Structural analysis, expression, and chromosomal localization of the mouse ikba gene.","date":"1999","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/10199915","citation_count":18,"is_preprint":false},{"pmid":"35777990","id":"PMC_35777990","title":"Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients.","date":"2022","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35777990","citation_count":18,"is_preprint":false},{"pmid":"37764703","id":"PMC_37764703","title":"The Circadian Nobiletin-ROR Axis Suppresses Adipogenic Differentiation and IκBα/NF-κB Signaling in Adipocytes.","date":"2023","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/37764703","citation_count":18,"is_preprint":false},{"pmid":"39427871","id":"PMC_39427871","title":"USP9X-enriched MSC-sEV inhibits LSEC angiogenesis in MASH mice by downregulating the IκBα/NF-κB/Ang-2 pathway.","date":"2024","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/39427871","citation_count":17,"is_preprint":false},{"pmid":"15858823","id":"PMC_15858823","title":"Germline mutations and polymorphisms in the NFKBIA gene in Hodgkin lymphoma.","date":"2005","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15858823","citation_count":17,"is_preprint":false},{"pmid":"20551178","id":"PMC_20551178","title":"Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.","date":"2010","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/20551178","citation_count":17,"is_preprint":false},{"pmid":"34224210","id":"PMC_34224210","title":"Dynamic chromatin association of IκBα is regulated by acetylation and cleavage of histone H4.","date":"2021","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/34224210","citation_count":17,"is_preprint":false},{"pmid":"28970077","id":"PMC_28970077","title":"FBXO32 activates NF-κB through IκBα degradation in inflammatory and genotoxic stress.","date":"2017","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28970077","citation_count":17,"is_preprint":false},{"pmid":"25520503","id":"PMC_25520503","title":"COMMD1/Murr1 reinforces HIV-1 latent infection through IκB-α stabilization.","date":"2014","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/25520503","citation_count":17,"is_preprint":false},{"pmid":"17318773","id":"PMC_17318773","title":"HLA, NFKB1 and NFKBIA gene polymorphism profile in autoimmune diabetes mellitus patients.","date":"2007","source":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","url":"https://pubmed.ncbi.nlm.nih.gov/17318773","citation_count":16,"is_preprint":false},{"pmid":"16539850","id":"PMC_16539850","title":"Deguelin inhibits expression of IkappaBalpha protein in Raji and U937 cells.","date":"2006","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/16539850","citation_count":16,"is_preprint":false},{"pmid":"38696874","id":"PMC_38696874","title":"Cadmium promoted LPS-induced inflammation through TLR4/IκBα/NFκ-B signaling by increasing ROS-mediated incomplete autophagy.","date":"2024","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/38696874","citation_count":16,"is_preprint":false},{"pmid":"23885315","id":"PMC_23885315","title":"Regulation and function of nuclear IκBα in inflammation and cancer.","date":"2012","source":"American journal of clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23885315","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52765,"output_tokens":11280,"usd":0.163747,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23508,"output_tokens":4079,"usd":0.109757,"stage2_stop_reason":"end_turn"},"total_usd":0.273504,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Crystal structure of the IκBα ankyrin repeat domain bound to a truncated NF-κB (p50/p65) heterodimer at 2.7 Å resolution reveals that six IκBα ankyrin repeats contact the C-terminal Rel homology regions of NF-κB in discontinuous patches; the first two repeats cover an alpha-helically ordered segment containing the p65 NLS, and the sixth repeat position indicates that full-length IκBα occludes the NF-κB DNA-binding cleft.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution crystal structure with functional interpretation; landmark single study with multiple orthogonal structural analyses\",\n      \"pmids\": [\"9865693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The F-box/WD-domain protein E3RSIκBα (β-TrCP) was identified as the receptor component of the pIκBα-ubiquitin ligase (pIκBα-E3) that specifically recognizes phosphorylated IκBα and promotes its in vitro ubiquitination in the presence of E1 and UBC5C; an F-box-deletion dominant-negative mutant blocked pIκBα degradation and NF-κB activation in vivo.\",\n      \"method\": \"Immunoaffinity purification from HeLa cells, nanoelectrospray mass spectrometry, in vitro ubiquitination assay, dominant-negative in vivo experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reconstituted in vitro ubiquitination, MS identification, confirmed with dominant-negative in vivo; single rigorous study with multiple orthogonal methods\",\n      \"pmids\": [\"9859996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Signal-induced NF-κB activation requires phosphorylation-dependent ubiquitination of IκBα: TNFα stimulation causes rapid accumulation of multi-ubiquitinated IκBα that dissociates from NF-κB when proteasomal degradation is blocked; an S32A/S36A IκBα mutant that cannot be phosphorylated also fails to undergo inducible ubiquitination, placing phosphorylation upstream of ubiquitination and proteasomal degradation.\",\n      \"method\": \"Proteasome inhibitor treatment, recombinant ubiquitin carboxyl-terminal hydrolase de-ubiquitination assay, anti-ubiquitin immunoprecipitation, epitope-tagged ubiquitin Western blot, site-directed mutagenesis\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal biochemical methods plus mutagenesis in a single rigorous study; foundational mechanistic result\",\n      \"pmids\": [\"8631829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Two distinct degradation pathways control IκBα levels: free IκBα is degraded rapidly in a ubiquitin-independent, PEST-domain-dependent manner by the proteasome, whereas NF-κB-bound IκBα is protected from this pathway and requires IKK phosphorylation and ubiquitination for slower basal degradation. NF-κB binding masks the PEST domain from proteasomal recognition.\",\n      \"method\": \"Biochemical fractionation, proteasome inhibitor assays, ubiquitination assays, PEST-domain deletion/mutation analysis, quantitative protein half-life measurements\",\n      \"journal\": \"The EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal biochemical methods distinguishing two degradation pathways; rigorous mechanistic dissection\",\n      \"pmids\": [\"18401342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"IκBα (when not bound to NF-κB) is constitutively and actively imported into the nucleus via an energy-dependent, importin α/β- and Ran-dependent mechanism that requires the ankyrin repeats of IκBα and additional factor(s) recognizing those repeats ('piggy-back' mechanism); binding to NF-κB retains IκBα in the cytoplasm.\",\n      \"method\": \"Nuclear import assays using digitonin-permeabilized cells, energy-depletion experiments, ankyrin-repeat competition/depletion from cell extracts, subcellular fractionation\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct nuclear transport assays with multiple biochemical manipulations in a single focused study\",\n      \"pmids\": [\"10037782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The cytoplasmic protein G3BP2 (RasGAP SH3-binding protein 2) interacts with both free IκBα and IκBα/NF-κB complexes via the N-terminal domain of IκBα, and its overexpression promotes cytoplasmic retention of IκBα, adding cytoplasmic anchoring to nuclear import/export as a mechanism controlling IκBα localization.\",\n      \"method\": \"Co-immunoprecipitation, pulldown, overexpression localization experiments, domain-mapping\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, reciprocal co-IP plus overexpression functional assay; two complementary methods\",\n      \"pmids\": [\"10969074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CK2 phosphorylation of serine/threonine residues in the PEST domain of IκBα (S283, T291, T299) promotes calpain-mediated degradation of IκBα, as demonstrated by in vitro CK2 phosphorylation/calpain degradation assays; a 3CIκBα mutant (S283A/T291A/T299A) resists calpain-mediated degradation, identifying a non-canonical degradation route active in IgM+ B cells.\",\n      \"method\": \"In vitro phosphorylation/degradation assay, site-directed mutagenesis (S283A/T291A/T299A), calpain inhibitor experiments, CK2 inhibitor (apigenin) treatment\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstituted phosphorylation-degradation assay with mutagenesis; single lab but mechanistically rigorous\",\n      \"pmids\": [\"11673497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"An IKK-independent IκBα degradation pathway exists: in IKK1/2−/− MEFs, doxorubicin induces IκBα degradation that does not require S32/S36 phosphorylation or the PEST domain, is partially blocked by PI3-kinase inhibitor LY294002, and is proteasome-dependent; the released NF-κB can activate chromatin-based reporter genes.\",\n      \"method\": \"IKK1/2 double-knockout MEFs, phospho-mutant IκBα, PI3-kinase inhibitor, proteasome inhibitor, NF-κB chromatin reporter assay\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — genetic knockout combined with pharmacological dissection and reporter assays; rigorous mechanistic characterization\",\n      \"pmids\": [\"14585967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"14-3-3 proteins physically interact with IκBα (residues 60–65) and with p65, and are required for efficient CRM1-dependent nuclear export of p65-IκBα complexes; mutations in the 14-3-3 binding domains cause nuclear accumulation of both proteins, and dominant-negative 14-3-3 leads to constitutive chromatin association of p65 with loss of TNFα responsiveness.\",\n      \"method\": \"Co-immunoprecipitation, domain-mapping mutagenesis, dominant-negative overexpression, ChIP, subcellular fractionation, fluorescence microscopy\",\n      \"journal\": \"Journal of Cell Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP, mutagenesis, dominant-negative functional assay, and ChIP in a single study; multiple orthogonal methods\",\n      \"pmids\": [\"16931600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Ionizing radiation activates NF-κB by a mechanism in which constitutive NO synthase activation leads to nitration of IκBα tyrosine 181, causing dissociation of intact IκBα from NF-κB without requiring IKK-dependent phosphorylation or proteolytic degradation of IκBα; crystallographic analysis shows Y181 is involved in noncovalent contacts with NF-κB p50.\",\n      \"method\": \"Cell-based NF-κB assays, NO synthase inhibitors, mutational analysis of Y181, hydropathic analysis of crystal structure contacts\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Weak — functional cell assays with pharmacological inhibitors and structural rationale; single lab, limited direct mutagenesis reconstitution\",\n      \"pmids\": [\"17910475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Stabilizing mutations in IκBα ankyrin repeats 5–6 cause them to pre-fold cooperatively; pre-folded IκBα is degraded more slowly by the ubiquitin-independent proteasome pathway, binds NF-κB more weakly (shown by SPR, ITC, and immunoprecipitation), and results in incomplete NF-κB inhibition at rest and reduced nuclear NF-κB upon stimulation, demonstrating that coupled folding-and-binding of IκBα is critical for NF-κB control.\",\n      \"method\": \"Stabilizing mutagenesis of AR5–6, surface plasmon resonance, isothermal titration calorimetry, co-immunoprecipitation, pulse-chase protein half-life assay in cells\",\n      \"journal\": \"Journal of Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted binding measurements plus mutagenesis plus cell-based half-life assays; multiple orthogonal methods in single study\",\n      \"pmids\": [\"18511071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TNFα stimulation induces formation of heterologous SUMO-2/3-ubiquitin chains on IκBα; deficient SUMOylation (Ubc9 silencing) delays TNFα-mediated IκBα proteolysis and NF-κB-dependent transcription; hybrid SUMO-2/3-ubiquitin chains promote more efficient degradation of IκBα by the 26S proteasome in vitro compared with either modification alone.\",\n      \"method\": \"In vitro proteasome degradation assay with hybrid chains, TUBE-based ubiquitin-trap capture, Ubc9 siRNA knockdown, TNFα stimulation assays\",\n      \"journal\": \"PloS One\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro reconstituted proteasome assay plus cell-based RNAi; single lab with two orthogonal methods\",\n      \"pmids\": [\"23284737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The p97-UFD1L-NPL4 protein complex mediates the post-ubiquitinational step of IκBα proteolysis after TNFα or IL-1β stimulation: p97 associates with the SCFβ-TRCP ubiquitin ligase, and UFD1L's polyubiquitin-binding domain binds polyubiquitinated IκBα; ATPase activity of p97 is essential for efficient IκBα degradation and NF-κB activation.\",\n      \"method\": \"Co-immunoprecipitation, ATPase-dead p97 mutant, siRNA knockdown, TNFα/IL-1β stimulation assays\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP with ATPase mutant and knockdown validation; single lab, two orthogonal methods\",\n      \"pmids\": [\"24248593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"IκBα can sequester ribosomal protein S3 (RPS3) in the cytoplasm: in resting HEK293 cells, RPS3 co-precipitates with IκBα; in vitro reconstitution shows strong direct IκBα–RPS3 binding but weak RPS3–p65 binding; IκBα facilitates assembly of p65 and RPS3 into a trimeric complex, suggesting equimolar co-release of RPS3 and p65 upon stimulation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding (pulldown), reconstitution of trimeric complex\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP combined with in vitro reconstitution; single lab\",\n      \"pmids\": [\"24457201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"IκBα binding to NF-κB induces long-range allosteric conformational changes: amide H/D exchange shows that IκBα binding to the dimerization domains globally stabilizes the DNA-binding domains, whereas DNA binding increases exchange in the NLS region, consistent with a 'molecular stripping' mechanism whereby IκBα electrostatically repels DNA and twists the NF-κB heterodimer.\",\n      \"method\": \"Hydrogen/deuterium exchange mass spectrometry (HDX-MS), coarse-grained molecular dynamics simulations\",\n      \"journal\": \"Journal of Molecular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — structural biophysics with HDX-MS; single lab, no mutagenesis confirmation of specific contacts\",\n      \"pmids\": [\"28249778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Transcriptional silencing of NFKBIA (encoding IκBα) by the histone demethylase KDM5B mediates constitutive NF-κB activation in senescent cells: during the second phase of DNA-damage-induced NF-κB activation, altered GSK3β-dependent phosphorylation of p65/RelA leads to NFKBIA transcriptional repression and IKK-independent, proteasome-independent NF-κB activity.\",\n      \"method\": \"RNA-seq, ChIP-seq, GSK3β inhibitor treatment, IKK inhibitor treatment, proteasome inhibitor treatment, siRNA knockdown\",\n      \"journal\": \"The EMBO Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide ChIP-seq and RNA-seq plus pharmacological dissection; single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"33459422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The histone demethylase KDM5B is recruited to the Nfkbia promoter in activated macrophages and erases H3K4me3 marks, reducing chromatin accessibility and suppressing IκBα expression to permit full NF-κB activation; KDM5B deficiency or inhibition protects mice from inflammatory disease models.\",\n      \"method\": \"Genome-wide ChIP-seq (KDM5B binding peaks), ATAC-seq (chromatin accessibility), KDM5B KO mice, inhibitor treatment, collagen-induced arthritis and endotoxin shock models\",\n      \"journal\": \"Cell Death and Differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq, ATAC-seq, genetic KO, and in vivo disease models; multiple orthogonal methods with in vivo validation\",\n      \"pmids\": [\"36914768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Hexokinase 2 (HK2) acts as a protein kinase that phosphorylates IκBα at T291 upon high-glucose stimulation; this phosphorylation increases IκBα interaction with μ-calpain, leading to μ-calpain-mediated IκBα degradation, NF-κB activation, and PD-L1 upregulation; expression of IκBα T291A blocked these effects.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, T291A phospho-mutant, calpain inhibitors, shRNA knockdown, orthotopic tumor models\",\n      \"journal\": \"Cell Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay plus phospho-mutant plus co-IP plus in vivo xenograft; multiple orthogonal methods in single study\",\n      \"pmids\": [\"36007522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TRIM22 E3 ubiquitin ligase directly binds IκBα (by co-immunoprecipitation), promotes K48-linked ubiquitination of IκBα accelerating its degradation, and also forms a complex with IKKγ to promote K63-linked ubiquitination leading to IKKα/β phosphorylation; RING-domain or active-site TRIM22 mutants fail to promote GBM cell proliferation.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assay, RING-domain deletion and C15/18A active-site mutagenesis, CRISPR/Cas9 knockout, orthotopic xenograft\",\n      \"journal\": \"Cell Death and Differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with E3 ligase mutants and in vivo xenograft; single lab, multiple complementary methods\",\n      \"pmids\": [\"32814880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HDAC4 acts as a SUMO E3 ligase (via its Cys292) that directly sumoylates IκBα; IκBα sumoylation at Lys21 competes with K48-linked polyubiquitination at the same residue, thereby preventing IκBα degradation and inhibiting NF-κB activation; cytoplasmic localization of HDAC4 is required for this activity.\",\n      \"method\": \"SUMO E3 ligase assay, co-immunoprecipitation, HDAC4 Cys292 mutagenesis, Lys21 IκBα mutation, subcellular fractionation\",\n      \"journal\": \"Journal of Molecular Cell Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct sumoylation assay with key-residue mutagenesis; single lab, two orthogonal methods\",\n      \"pmids\": [\"32770227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Gluconeogenic enzyme FBP1 directly dephosphorylates IκBα at S32/S36 upon TNFα stimulation: identified by phosphoproteomic analysis, confirmed by molecular docking and MD simulations showing catalytic mechanism analogous to F-1,6-BP dephosphorylation; FBP1-IκBα interaction established by co-immunoprecipitation; FBP1-dependent IκBα dephosphorylation inhibits NF-κB and suppresses colorectal tumorigenesis.\",\n      \"method\": \"High-throughput screening with molecular docking/MD simulations, phosphoproteomic analysis, co-immunoprecipitation, FBP1 overexpression/knockdown, colorectal tumor xenograft models\",\n      \"journal\": \"Cell Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphoproteomics plus co-IP plus in vivo models; computational predictions supported by experimental biochemistry; single lab\",\n      \"pmids\": [\"36646759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GRK6 directly phosphorylates IκBα at Ser32/Ser36 in vitro and in cells; TNFα induces a conformational change in GRK6 (detected by BRET probe), and GRK6 kinase activity promotes NF-κB signaling and inflammatory gene transcription after TNFα stimulation; GRK6 knockout in macrophages attenuates this response.\",\n      \"method\": \"In vitro kinase assay, GRK6 knockout macrophages, BRET conformational sensor, TNFα stimulation assays\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay plus genetic knockout plus BRET sensor; single lab, multiple methods\",\n      \"pmids\": [\"25881508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BCL10, MALT1, and IKK inducibly associate with IκBα in a complex physically distinct from the early CK1α-CBM signalosome during TCR signaling; siRNA knockdown of CARMA1, CK1α, or BCL10 prevents assembly of this IκBα-containing complex and reduces NF-κB activation; IκBα knockdown alters BCL10-MALT1 ubiquitylation, suggesting IκBα participates in MALT1 recycling.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown (CARMA1, CK1α, BCL10, IκBα), T-cell receptor stimulation assays\",\n      \"journal\": \"Journal of Cell Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — reciprocal co-IP with siRNA validation; single lab, two orthogonal approaches\",\n      \"pmids\": [\"20551178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Bmi1 polycomb protein associates with the SCF ubiquitin complex via its N-terminus and, following IKKα/β-dependent phosphorylation, promotes IκBα ubiquitination in the cytoplasm; Bmi1 deficiency inhibits NF-κB-mediated gene expression and an NF-κB-dependent arthritis model in vivo.\",\n      \"method\": \"Co-immunoprecipitation, Bmi1 N-terminal deletion mutants, IKK inhibitor, Bmi1 knockout, collagen-induced arthritis model\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with domain mapping plus in vivo disease model; single lab\",\n      \"pmids\": [\"30209188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"USP14 deubiquitinating enzyme interacts with IκBα and promotes its deubiquitination and degradation (paradoxically exacerbating NF-κB activation), thereby creating a feed-forward loop that aggravates IL-1β-induced chondrocyte dedifferentiation; USP14 upregulation itself depends on NF-κB pathway activity.\",\n      \"method\": \"Co-immunoprecipitation, USP14 overexpression/knockdown, IKK-β inhibitor (ACHP), Western blot, chondrocyte differentiation assays\",\n      \"journal\": \"Life Sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single co-IP with functional assays; the described USP14 mechanism (promoting degradation via deubiquitination) is counterintuitive and lacks in vitro reconstitution\",\n      \"pmids\": [\"30550885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Hypoxia (1% O2) inhibits RANKL-dependent phosphorylation of IκBα in osteoclast precursors, thereby suppressing NFATc1 expression and osteoclast differentiation and bone resorption.\",\n      \"method\": \"RAW264.7 cells and bone marrow monocytes in hypoxic chamber, RANKL stimulation, Western blot for p-IκBα and p-JNK, TRAP staining, bone resorption assay\",\n      \"journal\": \"Inflammation Research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, descriptive Western blot correlation between hypoxia and IκBα phosphorylation; no mechanistic reconstitution of hypoxia-IκBα link\",\n      \"pmids\": [\"30604211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Hypoxia induces rapid, transient accumulation of both RelA and IκBα within mitochondria in a ROS- and STAT3-dependent manner; STAT3 inhibition blocks mitochondrial RelA and IκBα localization; p50 is instead found in the ER and RelA alone is present in the mitoplast.\",\n      \"method\": \"Subcellular fractionation (mitochondria isolation), mitoplast fractionation, hypoxia treatment, ROS scavenger, STAT3 inhibitor, Western blot\",\n      \"journal\": \"Bioscience Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct fractionation with organelle sub-fractionation plus pharmacological inhibitors; single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"31484794\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Phosphorylated IκBα (pS-IκBα) binds to nucleosomes via histones H2A and H4; serine 32/36 phosphorylation of IκBα favors its binding to nucleosomes; this association depends on acetylation of specific H4 lysine residues; proteolytic cleavage of the H4 N-terminal tail by trypsin/chymotrypsin reduces pIκBα chromatin binding; dynamic chromatin binding of IκBα is required for intestinal cell differentiation.\",\n      \"method\": \"Chromatin immunoprecipitation, co-immunoprecipitation with nucleosome components, phospho-mutant IκBα, H4 acetylation analysis, trypsin/chymotrypsin inhibitor treatment, IκBα deletion in intestinal organoids\",\n      \"journal\": \"EMBO Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus co-IP with mutants and functional differentiation assay; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"34224210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP39 deubiquitinating enzyme interacts with IκBα and removes K48-linked polyubiquitin chains, stabilizing basal IκBα and suppressing NF-κB-mediated inflammatory responses; USP39 knockdown/knockout in macrophages increases pro-inflammatory cytokine secretion; USP39-defective mice are more sensitive to LPS-induced sepsis.\",\n      \"method\": \"Co-immunoprecipitation, USP39 siRNA/CRISPR knockout, K48-linked ubiquitination assay, LPS stimulation, in vivo sepsis model\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus ubiquitination assay plus in vivo model; single lab\",\n      \"pmids\": [\"36651806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Nuclear import rate, nuclear export rate of free IκBα, and the half-life of free IκBα are identified as critical determinants of post-induction NF-κB repression and the potential for NF-κB re-activation; NF-κB-inducible expression of IκBα alone is not sufficient for effective negative feedback—the biophysical properties of IκBα nuclear transport are also required.\",\n      \"method\": \"Computational modeling of NF-κB signaling, single-cell live imaging, biochemical half-life measurements, nuclear import/export perturbation experiments\",\n      \"journal\": \"Journal of the Royal Society Interface\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — computational predictions tested with live single-cell imaging and biochemical experiments; single lab\",\n      \"pmids\": [\"26311312\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"IκBα differentially regulates NF-κB subunit nuclear localization in a subunit composition-dependent manner: IκBα binding attenuates nuclear import potential of p65 and c-Rel homodimers but not p50-associated heterodimers, leading to a greater propensity of heterodimers to reside in the nucleus; c-Rel-IκBα complexes in mature B cells result in nuclear c-Rel accumulation following IκBα turnover and shuttling.\",\n      \"method\": \"Nuclear import assays, NLS mutagenesis, subcellular fractionation, nuclear export assay (CRM1 dependence), co-immunoprecipitation in B-cell lines\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — nuclear transport assays combined with fractionation and co-IP; single lab, multiple approaches\",\n      \"pmids\": [\"11416157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"N4BP3 interacts with IκBα and promotes K48-linked ubiquitination of IκBα, leading to NF-κB pathway activation; N4BP3 overexpression elevates K48-linked ubiquitination of IκBα and increases pro-inflammatory cytokine expression in THP-1 cells, whereas N4BP3 knockdown reduces IκBα ubiquitination and colitis severity in vivo.\",\n      \"method\": \"Co-immunoprecipitation, K48-linked ubiquitination assay, N4BP3 overexpression/knockdown, DSS-induced colitis mouse model, AAV-mediated knockdown\",\n      \"journal\": \"Journal of Inflammation Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with ubiquitination assay plus in vivo model; single lab\",\n      \"pmids\": [\"40487287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TRIM67 competes with IκBα for binding to β-TrCP, thereby inhibiting β-TrCP-mediated ubiquitination and degradation of IκBα and suppressing TNFα-triggered NF-κB activation; Trim67 deletion in MEFs promotes inflammatory gene expression after TNFα.\",\n      \"method\": \"Co-immunoprecipitation (TRIM67–β-TrCP–IκBα competition), Trim67 knockdown/knockout, TNFα stimulation assays, NF-κB reporter\",\n      \"journal\": \"Frontiers in Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — co-IP competition assay plus genetic knockout; single lab\",\n      \"pmids\": [\"35273593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FBXO32 F-box protein stabilizes and polyubiquitinates IκBα under genotoxic stress and inflammatory conditions, promoting proteasomal degradation of IκBα and NF-κB activation; FBXO32 also regulates basal IκBα levels in unstressed cells.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, FBXO32 overexpression/knockdown, genotoxic stress (doxorubicin) and LPS treatment\",\n      \"journal\": \"The International Journal of Biochemistry & Cell Biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, co-IP and ubiquitination assay without detailed domain mapping or in vitro reconstitution\",\n      \"pmids\": [\"28970077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"IκBα contains distinct functional domains for cytoplasmic versus nuclear regulation of c-Rel: the N-terminal and central ankyrin regions mediate cytoplasmic retention and NLS masking, while the central ankyrin domain and negatively charged residues in the C-terminal PEST domain are required for nuclear regulation of c-Rel.\",\n      \"method\": \"Domain-deletion mutagenesis of IκBα, subcellular fractionation, transcriptional reporter assays\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic deletion mapping with functional readouts; single lab, multiple domain constructs\",\n      \"pmids\": [\"9488436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"IκBα cytoplasmic sequestration of p65 is sufficient to translocate nuclear corepressors N-CoR/SMRT to the cytoplasm and upregulate Notch-dependent transcription; p65 and IκBα can directly bind SMRT, and this interaction is inhibited by CBP/p300 coactivator in a dose-dependent manner and by TNFα treatment, suggesting p65 acetylation modulates this cross-talk.\",\n      \"method\": \"Co-immunoprecipitation (p65–IκBα–SMRT), subcellular fractionation, reporter assays, TNFα stimulation\",\n      \"journal\": \"Molecular Biology of the Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — co-IP of trimeric complex plus functional reporter with competitor experiments; single lab\",\n      \"pmids\": [\"12589049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Purified protein kinase CKII directly phosphorylates IκBα at both S32 and S36 in vitro, and CKII immunoprecipitated from cells specifically associates with IκBα; this CKII kinase activity is biochemically distinct from the IKKα/β-containing signalsome complex.\",\n      \"method\": \"In vitro phosphorylation assay with purified CKII, immunoprecipitation of endogenous CKII-IκBα complex, phospho-site mapping\",\n      \"journal\": \"Journal of Molecular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay plus in vivo co-IP; single lab\",\n      \"pmids\": [\"10398585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"COMMD1/Murr1 stabilizes IκBα protein by increasing its interaction with IκBα and inhibiting proteasomal degradation in latently HIV-1-infected myeloid cells; COMMD1 induction by the PI3K-JAK pathway attenuates NF-κB signaling and enhances HIV-1 latency.\",\n      \"method\": \"Co-immunoprecipitation (COMMD1–IκBα), proteasome inhibitor assays, PI3K-JAK pathway inhibitors, Western blot in matched parental/latently infected cell lines\",\n      \"journal\": \"Journal of Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — co-IP plus pharmacological dissection; single lab, cell-line-based study\",\n      \"pmids\": [\"25520503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dimethylfumarate (DMF) reduces intracellular glutathione and induces glutathionylation of IκBα (IκBα-SSG), which inhibits IκBα degradation, NF-κB p65 nuclear entry, and NF-κB/DNA binding in airway smooth muscle cells; these effects are reversed by addition of GSH-OEt, confirming glutathionylation as the inhibitory modification.\",\n      \"method\": \"Co-immunoprecipitation of glutathionylated IκBα, EMSA (NF-κB/DNA binding), immunofluorescence, Western blot, GSH-OEt rescue\",\n      \"journal\": \"The European Respiratory Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct detection of IκBα-SSG plus functional rescue experiment; single lab, multiple readouts\",\n      \"pmids\": [\"21719482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PPARα activation potentiates p65-stimulated IκBα transcription in a ligand-dependent manner requiring the NF-κB and Sp1 sites in the IκBα promoter; this mechanism requires the coactivator DRIP205 but not CBP/p300; ChIP assays show PPARα activation enhances occupancy of the NF-κB response element in the IκBα promoter in vivo.\",\n      \"method\": \"Transient transfection luciferase assays, site-directed mutagenesis of NF-κB/Sp1 promoter sites, chromatin immunoprecipitation, dominant-negative DRIP205 overexpression\",\n      \"journal\": \"Molecular Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter mutagenesis plus ChIP plus dominant-negative; single lab\",\n      \"pmids\": [\"11981037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nur77 (orphan nuclear receptor) directly binds to a Nur77 response element in the IκBα promoter and transcriptionally upregulates IκBα expression; Nur77 overexpression increases IκBα protein ~4-fold, whereas dominant-negative Nur77 (lacking transactivation domain) has no effect; the resulting IκBα upregulation suppresses TNFα- and IL-1β-induced NF-κB activation and endothelial cell adhesion molecule expression.\",\n      \"method\": \"Adenoviral overexpression, dominant-negative Nur77, IκBα promoter-reporter assay, ChIP (Nur77 binding to IκBα promoter), Western blot, NF-κB activation assays\",\n      \"journal\": \"Circulation Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus promoter-reporter with dominant-negative validation; single lab\",\n      \"pmids\": [\"19213954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Tumor suppressor SMAR1 binds directly to the matrix attachment region (MAR) site in the IκBα promoter, recruits a corepressor complex, and represses IκBα transcription; this generates NF-κB complexes (p65-p50) that are DNA-binding competent but phosphorylation- and transactivation-deficient, suppressing a subset of NF-κB target genes involved in tumorigenesis.\",\n      \"method\": \"ChIP (SMAR1 binding to IκBα promoter MAR site), promoter-reporter assay, SMAR1 overexpression/siRNA, NF-κB target gene array\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with functional reporter and gene array; single lab\",\n      \"pmids\": [\"18981184\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"IκBα (NFKBIA) sequesters NF-κB dimers in the cytoplasm by masking the p65 NLS with its ankyrin repeats (crystal structure established) and occluding the DNA-binding cleft; upon inflammatory stimulation, IKK phosphorylates IκBα at S32/S36 (or GRK6/CKII can also phosphorylate these sites), triggering K48-linked polyubiquitination by SCFβ-TrCP and proteasomal degradation that is facilitated post-ubiquitinationally by the p97-UFD1L-NPL4 complex; free IκBα is also degraded constitutively via a ubiquitin-independent, PEST-domain-dependent proteasomal pathway; additional non-canonical degradation routes include calpain-mediated cleavage (promoted by CK2 PEST-domain phosphorylation or HK2-mediated T291 phosphorylation), an IKK-independent DNA-damage pathway, and tyrosine nitration (Y181) by radiation-induced NO; the degradation of IκBα is counteracted by multiple deubiquitinases (USP39, USP9X) and E3 competitors (TRIM67 competing with β-TrCP), and is enhanced by additional E3 ligases (TRIM22, Bmi1, FBXO32, N4BP3, ROC1); free IκBα is actively imported into the nucleus via importin α/β and its ankyrin repeats, where it can strip NF-κB from DNA (allosterically twisting the heterodimer) and export it via CRM1 facilitated by 14-3-3 proteins; NFKBIA transcription itself is a major NF-κB target providing negative feedback, and this feedback is further regulated epigenetically by KDM5B-mediated H3K4me3 erasure or by SMAR1/Nur77/PPARα binding to the IκBα promoter; phosphorylated IκBα also binds chromatin (histones H2A/H4) in a manner regulated by H4 acetylation, contributing to intestinal differentiation, and IκBα transiently localizes to mitochondria under hypoxia in a ROS/STAT3-dependent manner.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"IκBα (NFKBIA) is the principal cytoplasmic inhibitor of NF-κB, governing the inducibility and dynamics of NF-κB-dependent transcription in inflammation, development, and tumorigenesis [#0, #2]. Its ankyrin repeat domain clamps the C-terminal Rel homology regions of the p50/p65 heterodimer, masking the p65 nuclear localization signal and occluding the DNA-binding cleft so the dimer is retained in an inactive cytoplasmic state [#0]; binding is governed by coupled folding of ankyrin repeats 5–6, such that incomplete folding weakens NF-κB capture and compromises inhibition [#10]. Upon inflammatory signaling, IκBα is phosphorylated at S32/S36 — by IKK and additionally by CKII and GRK6 — which licenses recognition by the SCF^β-TrCP E3 ligase, K48-linked polyubiquitination, and proteasomal degradation, an obligatory order in which phosphorylation precedes ubiquitination [#2, #1, #36, #21]; the p97-UFD1L-NPL4 ATPase complex acts post-ubiquitinationally to drive efficient proteolysis [#12]. IκBα turnover is dual: free IκBα is degraded rapidly through a ubiquitin-independent, PEST-dependent proteasomal route, whereas NF-κB-bound IκBα masks the PEST domain and is degraded slowly via the phosphorylation/ubiquitination route [#3]. Multiple non-canonical routes also dismantle the inhibitor — CK2- or HK2(T291)-primed calpain cleavage, an IKK-independent genotoxic-stress pathway, and tyrosine-181 nitration that dissociates intact IκBα from NF-κB without proteolysis [#6, #17, #7, #9]. Beyond cytoplasmic sequestration, free IκBα is actively imported into the nucleus via its ankyrin repeats and importin α/β, where it strips NF-κB from DNA through long-range allosteric twisting of the heterodimer and exports it via CRM1 with 14-3-3 assistance, making nuclear transport kinetics a determinant of post-induction repression and re-activation [#4, #14, #8, #29]. NFKBIA is itself an NF-κB-inducible negative-feedback gene whose output is tuned epigenetically and transcriptionally, including KDM5B-mediated erasure of H3K4me3 at the promoter to permit full NF-κB activation [#16]. Phosphorylated IκBα additionally associates with nucleosomes via histones H2A/H4 in an H4-acetylation-dependent manner, contributing to intestinal epithelial differentiation [#27].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established the causal order of the canonical degradation switch — that signal-induced phosphorylation of IκBα is a prerequisite for its inducible ubiquitination and proteasomal destruction.\",\n      \"evidence\": \"TNFα stimulation with proteasome inhibition, anti-ubiquitin IP, and an S32A/S36A non-phosphorylatable mutant\",\n      \"pmids\": [\"8631829\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the E3 ligase that reads the phosphodegron\", \"Did not resolve the kinase responsible in vivo\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the structural basis of NF-κB inhibition, showing how ankyrin repeats mask the p65 NLS and occlude the DNA-binding cleft.\",\n      \"evidence\": \"2.7 Å X-ray crystal structure of the IκBα ankyrin domain bound to a truncated p50/p65 heterodimer\",\n      \"pmids\": [\"9865693\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Truncated NF-κB lacked full-length context\", \"Did not capture the molecular-stripping transition state\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identified β-TrCP as the substrate-recognition receptor that reads phospho-IκBα, completing the canonical phospho-ubiquitin module.\",\n      \"evidence\": \"Immunoaffinity purification with MS identification, in vitro reconstituted ubiquitination, and dominant-negative F-box mutant in vivo\",\n      \"pmids\": [\"9859996\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address post-ubiquitination handoff to the proteasome\", \"Did not address basal versus induced turnover\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed that free IκBα is not merely a static cytoplasmic anchor but is actively imported into the nucleus, establishing nuclear shuttling as part of its regulatory repertoire.\",\n      \"evidence\": \"Import assays in digitonin-permeabilized cells with importin α/β/Ran dependence and ankyrin-repeat competition\",\n      \"pmids\": [\"10037782\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the ankyrin-recognizing import factor not resolved\", \"Functional consequence of nuclear IκBα not yet shown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrated that S32/S36 phosphorylation is not exclusive to IKK, with CKII directly modifying the same sites, broadening the kinase input.\",\n      \"evidence\": \"In vitro kinase assay with purified CKII and co-IP of endogenous CKII-IκBα\",\n      \"pmids\": [\"10398585\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological signal triggering CKII phosphorylation unclear\", \"Relative contribution versus IKK in vivo not quantified\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Uncovered a non-canonical, calpain-dependent destruction route primed by CK2 phosphorylation of PEST-domain residues, distinct from the proteasomal pathway.\",\n      \"evidence\": \"In vitro CK2 phosphorylation/calpain degradation with an S283A/T291A/T299A mutant in IgM+ B cells\",\n      \"pmids\": [\"11673497\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological signal coupling CK2 to calpain not defined\", \"Generality beyond B cells unaddressed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed NF-κB can be activated through IKK-independent, phosphorylation- and PEST-independent IκBα degradation under genotoxic stress, revealing pathway redundancy.\",\n      \"evidence\": \"IKK1/2-double-knockout MEFs with doxorubicin, phospho-mutant IκBα, PI3K and proteasome inhibitors, chromatin reporter\",\n      \"pmids\": [\"14585967\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase for this route not identified here\", \"Degron recognized in absence of S32/S36 unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified 14-3-3 as an obligate partner for CRM1-dependent nuclear export of p65-IκBα complexes, linking export machinery to NF-κB termination.\",\n      \"evidence\": \"Reciprocal co-IP, domain mapping, dominant-negative 14-3-3, and ChIP\",\n      \"pmids\": [\"16931600\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether 14-3-3 binding is phospho-regulated not resolved\", \"Stoichiometry of the export complex undetermined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Resolved two kinetically distinct degradation pathways and showed NF-κB binding protects IκBα by masking its PEST domain, explaining how free versus bound pools are differentially controlled.\",\n      \"evidence\": \"Biochemical fractionation, proteasome and ubiquitination assays, PEST-domain mutants, protein half-life measurements\",\n      \"pmids\": [\"18401342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Proteasomal recognition of free PEST not structurally defined\", \"In vivo balance of the two pools not quantified\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrated that coupled folding-and-binding of ankyrin repeats 5–6 is functionally required, linking IκBα conformational dynamics to the strength of NF-κB inhibition and to its own turnover rate.\",\n      \"evidence\": \"Stabilizing AR5-6 mutagenesis with SPR, ITC, co-IP, and pulse-chase half-life assays\",\n      \"pmids\": [\"18511071\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo signaling consequences only inferred from cell assays\", \"Folding intermediates not structurally characterized\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Provided the biophysical mechanism of molecular stripping, showing IκBα allosterically destabilizes the DNA-bound state to actively remove NF-κB from DNA.\",\n      \"evidence\": \"HDX-MS coupled with coarse-grained molecular dynamics simulations\",\n      \"pmids\": [\"28249778\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No mutagenesis confirmation of the specific repulsive contacts\", \"Kinetics in living cells not measured\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The full set of E3 ligases, deubiquitinases, kinases, and metabolic enzymes reported to converge on IκBα has not been reconciled into a quantitative model of when each route dominates in a given cell type or stimulus.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Many regulators (e.g. TRIM22, N4BP3, FBXO32, USP14/USP39, HK2, FBP1) rest on single-lab co-IP/functional studies without in vitro reconstitution\", \"Cell-type and stimulus specificity of canonical versus non-canonical degradation unresolved\", \"Interplay between nuclear stripping, chromatin binding, and feedback transcription not integrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 10, 14]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [0, 4, 14]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3, 4, 5]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 8, 30]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [26]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 1]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [16, 28, 21]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [2, 3, 12]}\n    ],\n    \"complexes\": [\"NF-κB/IκBα (p50/p65) complex\", \"SCF^β-TrCP ubiquitin ligase\"],\n    \"partners\": [\"RELA\", \"NFKB1\", \"BTRC\", \"YWHA (14-3-3)\", \"G3BP2\", \"RPS3\", \"VCP (p97)\", \"TRIM67\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":8,"faith_total":8,"faith_pct":100.0}}